www.pacermonitor.com/public/case/26613171/Dacus_v_Bayer_HealthCare_Pharmaceuticals,_Inc_et_al

Jan 7, 2019 ... Dacus v. Bayer HealthCare Pharmaceuticals, Inc. et al (1:19-cv-00177), New York Southern District Court, Filed: 01/07/2019 - PacerMonitor ...

law.justia.com/cases/federal/district-courts/new-jersey/njdce/2:2011cv01576/255581/40

Mar 30, 2012 ... JAD BARGHOUT et al v. BAYER HEALTHCARE PHARMACEUTICALS et al, No. 2:2011cv01576 - Document 40 (D.N.J. 2012) case opinion ...

www.law360.com/cases/4d9b460c9f3b2561e4000003

Jan 30, 2015 ... BAYER HEALTHCARE PHARMACEUTICALS et al, case number ... Bayer Corp. has reached a deal Friday with current and former employees ...

caselaw.findlaw.com/us-federal-circuit/1878566.html

Case opinion for US Federal Circuit BAYER PHARMA AG v. ... Watson Laboratories, Inc. appeals the District of Delaware's final judgment holding Watson failed ..... to Market (Ghosh et al., eds., 2005) (“Ghosh”); (7) U.S. Patent Application Pub.

www.cooley.com/experience/case-in-point/onyx-v-bayer

Cooley delivered a significant win for longtime client Onyx Pharmaceuticals, ... Bayer will pay Onyx a royalty of 20% of future worldwide net sales of regorafenib in cancer. ... especially for me not knowing a lot of the medical and scientific terms.